abstract |
(57) [Summary]nThe present invention relates to the field of methods for treating and preventing ulcerative colitis. Specifically, the present invention involves administering a compound or recombinant protein that inhibits the interaction between CEP and human tropomyosin. The invention also includes methods of screening for drugs useful for treating ulcerative colitis, as well as diagnostic methods for detecting diseases associated with an autoantigen response to hTM in affected tissue. |